龙翔药业 (871082.OC)

+ 收藏

利润表(龙翔药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 99,444,425.51253,961,817.21112,477,440.82265,202,227.19112,445,550.77
 营业收入(元) 99,444,425.51253,961,817.21112,477,440.82265,202,227.19112,445,550.77
二、营业总成本(元) 116,527,914.90265,677,816.14114,281,991.70294,028,843.54118,218,437.39
 营业成本(元) 96,688,182.18215,059,173.3589,176,081.41241,960,193.78100,420,305.24
 研发费用(元) 3,053,613.317,910,566.734,655,205.059,951,107.121,688,068.44
 营业税金及附加(元) 1,165,759.651,970,064.40984,494.991,925,360.64914,088.27
 销售费用(元) 4,408,964.536,766,113.335,778,652.028,854,556.502,493,889.05
 管理费用(元) 5,411,014.1821,602,032.367,350,815.3319,013,381.297,325,585.50
 财务费用(元) 5,800,381.0512,369,865.976,336,742.9012,324,244.215,376,500.89
  其中:利息费用(元) 6,197,825.5312,875,458.526,734,881.9913,001,751.005,647,272.46
  其中:利息收入(元) 72,333.43197,911.58151,633.84409,579.72212,370.87
三、其他经营收益
 加:公允价值变动收益(元) -1,300,000.00-720,000.00-
 加:投资收益(元) ---195,000.00195,000.00
 资产处置收益(元) ----734.28-
 信用减值损失(元) -311,886.21-1,233,314.44171,423.56-786,373.06539,076.25
 其他收益(元) 1,638,057.043,126,948.202,000,068.754,346,515.483,709,447.76
四、营业利润(元) -15,757,318.56-8,522,365.17366,941.43-24,352,208.21-1,329,362.61
 加:营业外收入(元) 24,862.852,125,601.3581,160.082,844,440.162,447,517.30
 减:营业外支出(元) 330,114.0531,635.6421,535.64107,545.0522,094.47
五、利润总额(元) -16,062,569.76-6,428,399.46426,565.87-21,615,313.101,096,060.22
 减:所得税费用(元) -2,824,622.58-2,097,992.02-732,530.35-4,735,283.97-124,454.18
六、净利润(元) -13,237,947.18-4,330,407.441,159,096.22-16,880,029.131,220,514.40
  其中:被合并方在合并前实现利润(元) ----16,880,029.13-
(一)按经营持续性分类
  持续经营净利润(元) --4,330,407.44--16,880,029.131,220,514.40
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -13,237,947.18-4,330,407.441,159,096.22-16,880,029.131,220,514.40
 扣除非经常性损益后的净利润(元) -14,106,872.14-8,847,811.42-577,784.20-23,783,238.96-4,186,310.57
七、每股收益
 一、基本每股收益(元) -0.11-0.040.01-0.140.01
 二、稀释每股收益(元) -0.11-0.04--0.140.01
九、综合收益总额(元) --4,330,407.44--16,880,029.131,220,514.40
 归属于母公司所有者的综合收益总额(元) -13,237,947.18-4,330,407.441,159,096.22-16,880,029.131,220,514.40
公告日期 2024-08-232024-03-292023-08-252023-03-312022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院